Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.6.5.2 extracted from

  • Blanco, J.G.; Leisenring, W.M.; Gonzalez-Covarrubias, V.M.; Kawashima, T.I.; Davies, S.M.; Relling, M.V.; Robison, L.L.; Sklar, C.A.; Stovall, M.; Bhatia, S.
    Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer (2008), Cancer, 112, 2789-2795.
    View publication on PubMed
Search for more literature for 1.6.5.2

Application

Application Comment Organism
medicine NQO1 polymorphism analysis is performed using genomic DNA from buccal cell samples, anthracycline-related congestive heart failure is an important long-term complication among childhood cancer survivors, NQO1 polymorphism analysis indicated no association between the NQO1 polymorphism and the risk of anthracycline-related congestive heart failure Homo sapiens
medicine no association between NQO1 polymorphism and the risk of anthracycline-related congestive heart failure among childhood cancer survivors Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-
Homo sapiens
-
 patients with congestive heart failure after anthracycline treatment during childhood
-

Source Tissue

Source Tissue Comment Organism Textmining

Synonyms

Synonyms Comment Organism
NAD(P)H:quinone oxidoreductase
-
 Homo sapiens
NADPH:quinone oxidoreductase 1
-
 Homo sapiens
nicotinamide adenine dinucleotide phosphate:quinone oxidoreductase 1
-
 Homo sapiens
NQO1
-
 Homo sapiens
NQO1 NQO1*2 gene Homo sapiens